Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Humbert

Showing results (691-700 of 710) with videos related to

Pageof 71
Sort By:
Respiratory Medicine and Research|December 24, 2022
2022 Update of indications and contraindications for lung transplantation in FranceJérôme Le Pavec, Christophe Pison, Sandrine Hirschi, et al.
Cell Metabolism|May 3, 2024
Dietary intake and glutamine-serine metabolism control pathologic vascular stiffnessNesrine S Rachedi, Ying Tang, Yi-Yin Tai, et al.
The European Respiratory Journal|March 26, 2026
Prognostic factors in interstitial lung disease-associated pulmonary hypertension: data from the HYPID cohort and the French Pulmonary Hypertension RegistryRémi Diesler, Ségolène Turquier, Martine Reynaud-Gaubert, et al.
American Journal of Respiratory and Critical Care Medicine|September 14, 2010
Strategic plan for lung vascular research: An NHLBI-ORDR Workshop ReportSerpil Erzurum, Sharon I Rounds, Troy Stevens, et al.
American Journal of Respiratory and Critical Care Medicine|December 14, 2021
Aggressive Afterload Lowering to Improve the Right Ventricle: A New Target for Medical Therapy in Pulmonary Arterial Hypertension?Carmine Dario Vizza, Irene M Lang, Roberto Badagliacca, et al.
Cell|April 3, 2025
Therapeutic potential of allosteric HECT E3 ligase inhibitionAlexander M K Rothman, Amir Florentin, Florence Zink, et al.
American Journal of Respiratory and Critical Care Medicine|June 29, 2021
Association between Initial Treatment Strategy and Long-Term Survival in Pulmonary Arterial HypertensionAthénaïs Boucly, Laurent Savale, Xavier Jaïs, et al.
The European Respiratory Journal|September 30, 2021
Mendelian randomisation and experimental medicine approaches to interleukin-6 as a drug target in pulmonary arterial hypertensionMark Toshner, Colin Church, Lars Harbaum, et al.
Circulation|October 4, 2017
Phenotypic Characterization of <i>EIF2AK4</i> Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial HypertensionCharaka Hadinnapola, Marta Bleda, Matthias Haimel, et al.
American Journal of Respiratory and Critical Care Medicine|July 19, 2022
First Genotype-Phenotype Study in TBX4 Syndrome: Gain-of-Function Mutations Causative for Lung DiseaseMatina Prapa, Mauro Lago-Docampo, Emilia M Swietlik, et al.
Pageof 71

Showing results (691-700 of 710) with videos related to

Sort By:
Pageof 71
Respiratory Medicine and Research|December 24, 2022
2022 Update of indications and contraindications for lung transplantation in FranceJérôme Le Pavec, Christophe Pison, Sandrine Hirschi, et al.
Cell Metabolism|May 3, 2024
Dietary intake and glutamine-serine metabolism control pathologic vascular stiffnessNesrine S Rachedi, Ying Tang, Yi-Yin Tai, et al.
The European Respiratory Journal|March 26, 2026
Prognostic factors in interstitial lung disease-associated pulmonary hypertension: data from the HYPID cohort and the French Pulmonary Hypertension RegistryRémi Diesler, Ségolène Turquier, Martine Reynaud-Gaubert, et al.
American Journal of Respiratory and Critical Care Medicine|September 14, 2010
Strategic plan for lung vascular research: An NHLBI-ORDR Workshop ReportSerpil Erzurum, Sharon I Rounds, Troy Stevens, et al.
American Journal of Respiratory and Critical Care Medicine|December 14, 2021
Aggressive Afterload Lowering to Improve the Right Ventricle: A New Target for Medical Therapy in Pulmonary Arterial Hypertension?Carmine Dario Vizza, Irene M Lang, Roberto Badagliacca, et al.
Cell|April 3, 2025
Therapeutic potential of allosteric HECT E3 ligase inhibitionAlexander M K Rothman, Amir Florentin, Florence Zink, et al.
American Journal of Respiratory and Critical Care Medicine|June 29, 2021
Association between Initial Treatment Strategy and Long-Term Survival in Pulmonary Arterial HypertensionAthénaïs Boucly, Laurent Savale, Xavier Jaïs, et al.
The European Respiratory Journal|September 30, 2021
Mendelian randomisation and experimental medicine approaches to interleukin-6 as a drug target in pulmonary arterial hypertensionMark Toshner, Colin Church, Lars Harbaum, et al.
Circulation|October 4, 2017
Phenotypic Characterization of <i>EIF2AK4</i> Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial HypertensionCharaka Hadinnapola, Marta Bleda, Matthias Haimel, et al.
American Journal of Respiratory and Critical Care Medicine|July 19, 2022
First Genotype-Phenotype Study in TBX4 Syndrome: Gain-of-Function Mutations Causative for Lung DiseaseMatina Prapa, Mauro Lago-Docampo, Emilia M Swietlik, et al.
Pageof 71